Advancements in Host-Based Interventions for Influenza Treatment
Influenza is a major acute respiratory infection that causes mortality and morbidity worldwide. Two classes of conventional antivirals, M2 ion channel blockers and neuraminidase inhibitors, are mainstays in managing influenza disease to lessen symptoms while minimizing hospitalization and death in p...
Main Authors: | Tsz-Fung Yip, Aisha Sami Mohammed Selim, Ida Lian, Suki Man-Yan Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01547/full |
Similar Items
-
Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm
by: Si Chen, et al.
Published: (2019-06-01) -
Treating Influenza Infection, From Now and Into the Future
by: Sophia Davidson
Published: (2018-09-01) -
The benefits and risks of Echinacea in treatment of common cold and influenza
by: Yenny Yenny, et al.
Published: (2008-09-01) -
Predicting the host of influenza viruses based on the word vector
by: Beibei Xu, et al.
Published: (2017-07-01) -
Proteinaceous molecules mediating Bifidobacterium-host interactions
by: Lorena Ruiz, et al.
Published: (2016-08-01)